[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [PBNCategory](https://github.com/mm80843/T3.5/tree/main/docs/PBNCategory/index.md) >> Individual ID:PBN__PBNCategory_460 

# __Implement comprehensive, widespread testing and contact tracing programs to monitor and control the spread of the virus.__

## Items covered in this category

* [Universal asymptomatic rt-pcr testing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1220.md)
* [Implement regular testing, contact tracing, and isolation measures](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1458.md)
* [Widespread testing and contact tracing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_720.md)
* [Implementation of contact tracing and testing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_462.md)
* [Reduced time from diagnosis to surgery](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_163.md)
* [Monitor reactions, provide psychosocial support and assistance, modify expectations](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2495.md)
* [Evaluate efficacy differences based on symptoms](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1186.md)
* [Implement measures early, based on evidence and research](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1846.md)
* [Voluntary testing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_161.md)
* [Widespread testing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_441.md)
* [Testing policy](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_772.md)
* [Improve contact tracing systems, increase testing capacity, utilize digital tools for contact tracing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2722.md)
* [Rapid diagnosis](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3758.md)
* [Enhanced diagnostic techniques](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3759.md)
* [Rapid diagnostic tests](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1280.md)
* [Explore the use of additional physiological measurements to improve accuracy of diagnosis](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1558.md)
* [Monitor and manage gastrointestinal symptoms, enhance diagnostic capabilities](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2212.md)
* [Continuous monitoring and adjustment of treatment processes.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2514.md)
* [Combined use of wbe followed by clinical testing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1204.md)
* [Recognizing stress symptoms](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_208.md)
* [Staff respiratory specimens testing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_267.md)
* [Patient respiratory and stool specimens testing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_268.md)
* [Diagnostic testing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_4683.md)
* [Diagnostic tests](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_4682.md)
* [Testing of feces or anal swab samples](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1094.md)
* [Research and testing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_4465.md)
* [Isolate and test with school closure](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_425.md)
* [Attention to liver transplant recipients with metabolic comorbidities](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_365.md)
* [Differential testing rates](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_682.md)
* [Increase testing capacity, improved testing methods](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2126.md)
* [Health screening of workers](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1059.md)
* [Optimizing experimental conditions](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2987.md)
* [Forced experimentation](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_431.md)
* [Conduct controlled experiments, consider confounding factors in analysis](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1707.md)
* [Testing and surveillance](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3128.md)
* [Rapid testing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_4673.md)
* [Regular testing and contact tracing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_440.md)
* [Regular testing and contact tracing programs](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2757.md)
* [Increased testing and contact tracing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_864.md)
* [Increase testing capacity, develop rapid and accurate test kits, promote widespread testing](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2720.md)
* [Increase testing capacity; develop and deploy widespread testing strategies](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1887.md)
* [Promoting regular testing, contact tracing, and adherence to preventive measures](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1701.md)
* [Increase production and distribution of testing kits](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2281.md)
* [Increase testing frequency](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1187.md)
* [Prioritize testing and protection for vulnerable populations, such as the elderly and those with underlying health conditions.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3060.md)
* [Rapid antigen tests](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3150.md)
* [Robot-assisted swabbing and blood testing can speed up the process and free up staff for other tasks.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3080.md)
* [Conduct clinical trials to determine the efficacy of drug therapies, develop new therapeutics](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1594.md)
* [Screening techniques](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1410.md)
* [Combining multiple screening methods, widespread testing programs.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3046.md)
* [Early detection](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_4415.md)
* [Utilize cross-population train/test-based models](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2373.md)
* [Increased testing in deprived areas](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_683.md)
* [Increased testing in densely pop.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_684.md)
* [Improve testing methods, consider testing capacity](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2044.md)
* [Develop rapid testing methods to reduce turnaround time](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3114.md)
* [Increase testing capacity and accessibility in deprived areas.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2537.md)
* [Increased testing access](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1374.md)
* [Increase testing capacity and accessibility, prioritize testing for high-risk individuals and areas, utilize alternative testing methods such as wastewater-based surveillance.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3070.md)
* [Increase testing capacity to include testing of mild or asymptomatic individuals to obtain a more accurate assessment of the prevalence.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2560.md)
* [Improve testing frequency and accuracy, conduct seroprevalence surveys.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2511.md)
* [Expand testing capacity, prioritize testing for high-risk individuals and settings, implement targeted testing strategies](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2029.md)
* [Encouraging mixed-use developments](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_705.md)
* [Address safety concerns through research, testing, and regulation](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2370.md)
* [Reduce positivity rate through increased testing and strict adherence to mitigation measures](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2357.md)
* [Improve testing capacity and accuracy, enhance reporting systems](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2361.md)
* [Combine direct measurements with numerical simulations to inform decision-making, conduct rigorous study on intervention effectiveness](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2007.md)
* [Preprint servers can implement additional screening measures, and researchers should critically evaluate the quality of preprints before drawing conclusions.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3027.md)
* [Improve testing and reporting systems, increase transparency](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2847.md)
* [Implement regular and widespread symptom monitoring and testing, both symptomatic and asymptomatic](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2036.md)
* [Promote awareness about asymptomatic transmission, encourage individuals to practice preventive measures regardless of symptoms](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2312.md)
* [Develop and promote non-invasive testing methods, such as saliva or wastewater-based surveillance, to increase testing uptake.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3071.md)
* [Use of blockchain for diagnosis confirmation](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1172.md)
* [Evaluate the difference in efficacy between symptomatic and asymptomatic individuals.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2513.md)
* [Ultrabrief psychological interventions ubpi](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1235.md)
* [Conducting research studies and gathering quantitative data on the outcomes and effectiveness of ubpi.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2917.md)
* [Research and evaluation of ubpi effectiveness](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1237.md)
* [Conduct validation studies with reliable reference tests and establish validation standards](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1714.md)
* [Develop standardized and optimized testing protocols, enhance coordination and cooperation at national and international levels](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1793.md)
* [Conduct more efficacy studies in clinical settings to evaluate the impact of these measures on tb transmission](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1860.md)
* [Improve test sensitivity and accuracy to minimize false-negative results](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3115.md)
* [Allocate resources for testing and treatment, improve laboratory conditions.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2708.md)
* [Conduct studies on survival capacity](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3017.md)

